Re Pan Pharmaceuticals Ltd

The case of Re Pan Pharmaceuticals Ltd involved the administrators of Pan Pharmaceuticals Limited and its subsidiaries who sought a 75-day extension for convening a creditors' meeting under section 439A of the Corporations Act 2001 (Cth). The primary issue before the court was whether the administrators should be granted an extension to the convening period for the meeting of creditors, and if so, whether the decision should rest with the creditors at the meeting. James Selim, a director and contributory of Pan, opposed the extension and made submissions pursuant to leave granted by the court.

The court considered the discretion to grant an extension under section 439A(2) of the Corporations Act, which allows for a meeting to be convened within a five-business-day period after the appointment of administrators. The court also evaluated the arguments presented by Mr. Selim, who contended that the decision on whether to extend the convening period should be left to the creditors at the meeting. The court noted that the administrators had already taken significant steps to manage the administration process, including meeting with creditors, overseeing the product recall, and engaging with the Therapeutic Goods Administration. Given the complexity of the situation and the extensive work required, the court found that an extension was warranted to allow the administrators to complete their tasks effectively.

In granting the extension, the court emphasized that the decision to convene the meeting earlier should depend on the outcome of discussions with the Therapeutic Goods Administration regarding the reinstatement of Pan's manufacturing licence. The court also noted that if the administrators were in a position to convene the meeting earlier, they would apply for an order under section 447A of the Act to advance the meeting. The court concluded that, given the circumstances, the 75-day extension sought by the administrators should be granted. The final orders extended the convening periods for the meetings of creditors of Pan Pharmaceuticals Limited and its subsidiaries for a period of 75 days.